Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001654954-21-006923
Filing Date
2021-06-15
Accepted
2021-06-15 16:33:13
Documents
1
Period of Report
2021-02-25

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT section16.html 3  
1 PRIMARY DOCUMENT section16.xml 3 2556
  Complete submission text file 0001654954-21-006923.txt   4262
Mailing Address ONE COPLEY PARKWAY SUITE 490 MORRISVILLE NC 27560
Business Address ONE COPLEY PARKWAY SUITE 490 MORRISVILLE NC 27560 919-806-4414
TENAX THERAPEUTICS, INC. (Issuer) CIK: 0000034956 (see all company filings)

EIN.: 262593535 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address OMTHERA PHARMACEUTICALS, INC. 707 STATE ROAD PRINCETON NJ 08540
Business Address
Davidson Michael H. (Reporting) CIK: 0001573785 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-34600 | Film No.: 211018913